Anesthesia Respiratory & Sleep Therapy Devices Market Size, Share & Trends Analysis | Global | 2025-2032 | MedSuite | Includes: Anesthesia Devices, Respiratory Devices, Sleep Management Devices, and 4 more

Product Description

Overall, the Anesthesia Respiratory & Sleep Therapy Devices Market market was valued at $ 14 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.7% to reach approximately $19.2 billion.

The full report suite on the global anesthesia, respiratory and sleep management (ARS) device market covers a wide range of technologies used in hospital, surgical and homecare environments. These include anesthesia delivery units, anesthesia monitors, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy, therapeutic obstructive sleep apnea devices, sleep diagnostics devices, extracorporeal membrane oxygenation systems and anesthesia information management systems.

Data Types Included

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Market Drivers & Limiters
• Market Forecasts Until 2032, and Historical Data to 2022
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

Global Anesthesia Respiratory & Sleep Therapy Devices Market Trends

Ongoing technological advancements across anesthesia and respiratory care equipment are further supporting market expansion. Manufacturers are introducing more advanced anesthesia workstations, respiratory monitoring platforms and sleep diagnostic technologies designed to improve treatment accuracy, patient safety and clinical workflow efficiency. Integration of digital monitoring capabilities and data-driven clinical management tools is also contributing to the modernization of respiratory and sleep care.

Global Anesthesia Respiratory & Sleep Therapy Devices Market Share Insights

• ResMed led the global anesthesia, respiratory and sleep management device market in 2025 in large part due to its significant lead in the therapeutic obstructive sleep apnea market, by far the largest market within ARS. Additionally, ResMed’s biggest competitor, Philips, has faced product recalls over the past few years, allowing ResMed to further its lead in the market. ResMed is also involved in the ventilator and sleep diagnostics markets.
• Medtronic was a significant competitor in the global anesthesia, respiratory and sleep management device market in 2025 largely due to its leadership position in the extracorporeal membrane oxygenation (ECMO) segment, supported by an established ECMO platform and component portfolio such as the VitalFlow ECMO system and oxygenators designed for ECMO circuits. In addition, Medtronic maintains a meaningful presence in both anesthesia disposables and respiratory disposables, which aligns with its high-utilization, single-patient-use airway management portfolio, including endotracheal tubes indicated for intubation during anesthesia procedures and designed as sterile, single-patient-use devices. Medtronic also has a presence in the ventilator market; however, an important forward-looking consideration is that the company has publicly announced plans to wind down and exit its ventilator product line, while continuing service and support obligations, as well as certain consumables and accessories during the service life of installed systems.
• Inogen’s competitive presence in the global anesthesia, respiratory and sleep management device market in 2025 was driven primarily by the oxygen concentrator segment, reflecting the company’s strategy and revenue mix as a respiratory-focused manufacturer whose core business revolves around portable oxygen concentrators and related accessories. In its most recent annual filings, Inogen indicates that the majority of its revenue is derived from the sale and rental of portable oxygen concentrator systems and associated accessories, with a portfolio that includes portable systems such as the Inogen One and Inogen Rove, as well as stationary concentrators including the At Home and Voxi series. Inogen also notes that the oxygen therapy market includes numerous device manufacturers and highlights that Philips Respironics announced it would leave the U.S. portable oxygen concentrator market pending further regulatory assessments, a development that may reduce competitive intensity in certain distribution channels. Finally, while the company appears absent from most other ARS segments in the provided table, Inogen has begun expanding beyond oxygen therapy, including distribution of continuous positive airway pressure (CPAP) masks, suggesting that its current concentration in oxygen concentrators reflects product scale and market classification rather than a complete absence of activity in adjacent respiratory categories.

Global Anesthesia Respiratory & Sleep Therapy Devices Market Segmentation Summary

• Anesthesia Market – Further Segmented Into:
  • Device Type: Anesthesia Delivery Unit, Anesthesia Monitor, and Anesthesia Disposables.
• Respiratory Market – Further Segmented Into:
  • Device Type: Ventilator, Nebulizer, and Respiratory Disposables.
• Oxygen Therapy Market – Further Segmented Into:
  • Device Type: Oxygen Concentrator, Transfilling Device, and Aluminum Medical Oxygen Cylinder.
• Sleep Management Market – Further Segmented Into:
  • Device Type: Therapeutic Obstructive Sleep Apnea Device, and Sleep Diagnostics Device.
• Extracorporeal Membrane Oxygenation (ECMO) Market – Further Segmented Into:
  • Device Type: ECMO Machine Market, and ECMO Disposables Market.
• Anesthesia Information Management System Market

Research Scope Summary